{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:13:34Z","timestamp":1790208814715,"version":"4.1.0"},"reference-count":63,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Fam Plann Reprod Health Care"],"accepted":{"date-parts":[[2009,5,31]]},"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1783\/147118909788708147","type":"journal-article","created":{"date-parts":[[2009,7,4]],"date-time":"2009-07-04T15:20:18Z","timestamp":1246720818000},"page":"187-194","source":"Crossref","is-referenced-by-count":23,"title":["Management of premenstrual syndrome"],"prefix":"10.1136","volume":"35","author":[{"given":"Nick","family":"Panay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2009,7,1]]},"reference":[{"key":"ref_1","article-title":"Obstetricians and Gynaecologists (RCOG). Management of Premenstrual Syndrome (Green-top Guideline No","author":"of, Royal College","year":"2007","unstructured":"Royal College of Obstetricians and Gynaecologists (RCOG). Management of Premenstrual Syndrome (Green-top Guideline No. 48), Panay N (ed.). December 2007. http:\/\/www.rcog.org.uk\/files\/rcog-corp\/uploaded-files\/GT48Management PremensturalSyndrome.pdf [Accessed 10 May 2009]."},{"key":"ref_2","first-page":"334","article-title":"The premenstrual syndrome","volume-title":"Progress in Obstetrics and Gynaecology","author":"Magos, A.L.; Studd, J.W.W.","year":"1984","unstructured":"Magos AL, Studd JWW. The premenstrual syndrome. In: Studd J (ed.), Progress in Obstetrics and Gynaecology (Vol. 4). London, UK: Churchill Livingstone, 1984; 334\u2013350."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/09513590601167969","article-title":"Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies","volume":"23","author":"Halbreich, U.; Backstrom, T.; Eriksson, E.; O\u2019Brien, S.; Calil, H.; Ceskova, E.","year":"2007","unstructured":"Halbreich U, Backstrom T, Eriksson E, O\u2019Brien S, Calil H, Ceskova E, et al. Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies. Gynecol Endocrinol 2007; 23: 123\u2013130.","journal-title":"Gynecol Endocrinol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/09513599809012838","article-title":"The psychotherapeutic effects of estrogens","volume":"12","author":"Panay, N.; Studd, J.W.W.","year":"1998","unstructured":"Panay N, Studd JWW. The psychotherapeutic effects of estrogens. Gynecol Endocrinol 1998; 12: 353\u2013365.","journal-title":"Gynecol Endocrinol"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.biopsych.2006.12.019","article-title":"Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene","volume":"62","author":"Huo, L.; Straub, R.E.; Roca, C.; Schmidt, P.J.; Shi, K.; Vakkalanka, R.","year":"2007","unstructured":"Huo L, Straub RE, Roca C, Schmidt PJ, Shi K, Vakkalanka R, et al. Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene. Biol Psychiatry 2007; 62: 925\u2013933.","journal-title":"Biol Psychiatry"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1056\/NEJM199104253241710","article-title":"Premenstrual syndrome","volume":"324","author":"Reid, R.L.","year":"1991","unstructured":"Reid RL. Premenstrual syndrome. N Eng J Med 1991; 324: 1208\u20131210.","journal-title":"N Eng J Med"},{"issue":"2","key":"ref_7","first-page":"15","article-title":"A study to investigate the relationship between lifestyle factors and premenstrual symptoms","volume":"10","author":"Sadler, C.; Inskip, H.; Smith, H.; Panay, N.","year":"2004","unstructured":"Sadler C, Inskip H, Smith H, Panay N. A study to investigate the relationship between lifestyle factors and premenstrual symptoms. Menopause Int 2004; 10(Suppl. 2): 15.","journal-title":"Menopause Int"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00737-005-0103-y","article-title":"Daily Record of Severity of Problems (DRSP): reliability and validity","volume":"9","author":"Endicott, J.; Nee, J.; Harrison, W.","year":"2006","unstructured":"Endicott J, Nee J, Harrison W. Daily Record of Severity of Problems (DRSP): reliability and validity. Arch Womens Ment Health 2006; 9: 41\u201349.","journal-title":"Arch Womens Ment Health"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0015-0282(16)59045-1","article-title":"Conditioning exercise decreases premenstrual symptoms: a prospective, controlled 6-month trial","volume":"47","author":"Prior, J.C.; Vigna, Y.; Sciarretta, D.; Alojado, N.; Schulzer, M.","year":"1987","unstructured":"Prior JC, Vigna Y, Sciarretta D, Alojado N, Schulzer M. Conditioning exercise decreases premenstrual symptoms: a prospective, controlled 6-month trial. Fertil Steril 1987; 47: 402\u2013408.","journal-title":"Fertil Steril"},{"issue":"5","key":"ref_10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1067\/mob.2003.403","article-title":"An integrative medicine approach to premenstrual syndrome","volume":"188","author":"Girman, A.; Lee, R.; Kligler, B.","year":"2003","unstructured":"Girman A, Lee R, Kligler B. An integrative medicine approach to premenstrual syndrome. Am J Obstet Gynecol 2003; 188 (5 Suppl.): S56\u2013S65.","journal-title":"Am J Obstet Gynecol"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1471-0528.1990.tb02582.x","article-title":"Vitamin B6 in the treatment of premenstrual syndrome \u2013 a review","volume":"97","author":"Kleijnen, J.; Ter Riet, G.; Knipschild, P.","year":"1990","unstructured":"Kleijnen J, Ter Riet G, Knipschild P. Vitamin B6 in the treatment of premenstrual syndrome \u2013 a review. Br J Obstet Gynaecol 1990; 97: 847\u2013852.","journal-title":"Br J Obstet Gynaecol"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/bmj.318.7195.1375","article-title":"Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review","volume":"318","author":"Wyatt, K.; Dimmock, P.; Jones, P.; O\u2019Brien, P.","year":"1999","unstructured":"Wyatt K, Dimmock P, Jones P, O\u2019Brien P. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ 1999; 318: 1375\u20131381.","journal-title":"BMJ"},{"key":"ref_13","first-page":"177","article-title":"Oral magnesium successfully relieves premenstrual mood changes","volume":"78","author":"Facchinetti, F.; Borella, P.; Sances, G.; Fioroni, L.; Nappi, R.E.; Genazzani, A.R.","year":"1991","unstructured":"Facchinetti F, Borella P, Sances G, Fioroni L, Nappi RE, Genazzani AR. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol 1991; 78: 177\u2013181.","journal-title":"Obstet Gynecol"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1089\/jwh.1998.7.1157","article-title":"Magnesium supplementation alleviates premenstrual symptoms of fluid retention","volume":"7","author":"Walker, A.F.; De Souza, M.C.; Vickers, M.F.; Abeyasekera, S.; Collins, M.L.; Trinca, L.A.","year":"1998","unstructured":"Walker AF, De Souza MC, Vickers MF, Abeyasekera S, Collins ML, Trinca LA. Magnesium supplementation alleviates premenstrual symptoms of fluid retention. J Womens Health 1998; 7: 1157\u20131165.","journal-title":"J Womens Health"},{"key":"ref_15","first-page":"131","article-title":"A synergistic effect of a daily supplement","volume":"9","author":"MC, De Souza; AF, Walker; PA, Robinson; K, Bolland","year":"2000","unstructured":"De Souza MC, Walker AF, Robinson PA, Bolland K. A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxietyrelated premenstrual symptoms: a randomized, double-blind, crossover study. J Womens Health Gend Based Med 2000; 9: 131\u2013139.","journal-title":"J Womens Health Gend Based Med; magnesium plus 50 mg vitamin B6 for the relief of anxietyrelated premenstrual symptoms: a randomized, double-blind, crossover study"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/archinte.165.11.1246","article-title":"Calcium and vitamin D intake and risk of incident premenstrual syndrome","volume":"165","author":"Bertone-Johnson, E.R.; Hankinson, S.E.; Bendich, A.; Johnson, SR, Willett; WC, Manson; J.E.","year":"2005","unstructured":"Bertone-Johnson ER, Hankinson SE, Bendich A, Johnson SR, Willett WC, Manson JE. Calcium and vitamin D intake and risk of incident premenstrual syndrome. Arch Intern Med 2005; 165: 1246\u20131252.","journal-title":"Arch Intern Med"},{"key":"ref_17","first-page":"145","article-title":"Premenstrual and menstrual symptom clusters and response to calcium treatment","volume":"27","author":"Alvir, J.M.; Thys-Jacobs, S.","year":"1991","unstructured":"Alvir JM, Thys-Jacobs S. Premenstrual and menstrual symptom clusters and response to calcium treatment. Psychopharmacol Bull 1991; 27: 145\u2013148.","journal-title":"Psychopharmacol Bull"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF02599520","article-title":"Calcium supplementation in premenstrual syndrome: a randomized crossover trial","volume":"4","author":"Thys-Jacobs, S.; Ceccarelli, S.; Bierman, A.; Weisman, H.; Cohen, M.A.; Alvir, J.","year":"1989","unstructured":"Thys-Jacobs S, Ceccarelli S, Bierman A, Weisman H, Cohen MA, Alvir J. Calcium supplementation in premenstrual syndrome: a randomized crossover trial. J Gen Intern Med 1989; 4: 183\u2013189.","journal-title":"J Gen Intern Med"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0002-9378(98)70377-1","article-title":"Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group","volume":"179","author":"Thys-Jacobs, S.; Starkey, P.; Bernstein, D.; Tian, J.","year":"1998","unstructured":"Thys-Jacobs S, Starkey P, Bernstein D, Tian J. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group. Am J Obstet Gynecol 1998; 179: 444\u2013452.","journal-title":"Am J Obstet Gynecol"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0753-3322(02)00181-6","article-title":"Randomized, controlled trial of phytoestrogen in the prophylactic treatment of menstrual migraine","volume":"56","author":"Burke, B.E.; Olson, R.D.; Cusack, B.J.","year":"2002","unstructured":"Burke BE, Olson RD, Cusack BJ. Randomized, controlled trial of phytoestrogen in the prophylactic treatment of menstrual migraine. Biomed Pharm 2002; 56: 283\u2013288.","journal-title":"Biomed Pharm"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0378-5122(09)70459-1","article-title":"Randomised placebo controlled pilot study comparing red clover (P-07) versus placebo for the treatment of premenstrual syndrome","volume":"63","author":"Taher, S.; Cahill, A.; Eliahoo, J.; Calvin, M.; Rothon, C.; Panay, N.","year":"2009","unstructured":"Taher S, Cahill A, Eliahoo J, Calvin M, Rothon C, Panay N. Randomised placebo controlled pilot study comparing red clover (P-07) versus placebo for the treatment of premenstrual syndrome. Maturitas 2009; 63: S114\u2013S115.","journal-title":"Maturitas"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/bmj.322.7279.134","article-title":"Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebocontrolled study","volume":"322","author":"Schellenberg, R.","year":"2001","unstructured":"Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebocontrolled study. BMJ 2001; 322: 134\u2013137.","journal-title":"BMJ"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0944-7113(97)80066-9","article-title":"Treatment of premenstrual tension syndrome with Vitex agnus castus. Controlled, double-blind study versus pyridoxine","volume":"4","author":"Lauritzen, C.; Reuter, H.D.; Repges, R.","year":"1997","unstructured":"Lauritzen C, Reuter HD, Repges R, et al. Treatment of premenstrual tension syndrome with Vitex agnus castus. Controlled, double-blind study versus pyridoxine. Phytomedicine 1997; 4: 183\u2013189.","journal-title":"Phytomedicine"},{"key":"ref_24","article-title":"Treatment for premenstrual syndrome with Vitex agnus castus: a prospective, randomized, multi-center placebo controlled study in China","author":"He, Z.; Chen, R.; Zhou, Y.; Geng, L.; Zhang, Z.; Chen, S.","year":"2009","unstructured":"He Z, Chen R, Zhou Y, Geng L, Zhang Z, Chen S, et al. Treatment for premenstrual syndrome with Vitex agnus castus: a prospective, randomized, multi-center placebo controlled study in China. Maturitas 2009; 6 March [Epub ahead of print].","journal-title":"Maturitas"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1471-0528.2000.tb11085.x","article-title":"A pilot study of Hypericum perforatum (St John\u2019s Wort) for the treatment of premenstrual syndrome","volume":"107","author":"Stevinson, C.; Ernst, E.","year":"2000","unstructured":"Stevinson C, Ernst E. A pilot study of Hypericum perforatum (St John\u2019s Wort) for the treatment of premenstrual syndrome. Br J Obstet Gynaecol 2000; 107: 870\u2013876.","journal-title":"Br J Obstet Gynaecol"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2190\/RERY-N6AC-NADC-EHY4","article-title":"John\u2019s wort (Hypericum perforatum) as a treatment for premenstrual dysphoric disorder: case report","volume":"33","author":"Huang, K.L.; St, Tsai S.J.","year":"2003","unstructured":"Huang KL, Tsai SJ. St. John\u2019s wort (Hypericum perforatum) as a treatment for premenstrual dysphoric disorder: case report. Int J Psychiatry Med 2003; 33: 295\u2013297.","journal-title":"Int J Psychiatry Med"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.5694\/j.1326-5377.1990.tb136857.x","article-title":"Evening primrose oil and treatment of premenstrual syndrome","volume":"153","author":"Khoo, S.K.; Munro, C.; Battistutta, D.","year":"1990","unstructured":"Khoo SK, Munro C, Battistutta D. Evening primrose oil and treatment of premenstrual syndrome. Med J Aust 1990; 153: 189\u2013192.","journal-title":"Med J Aust"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0197-2456(95)00082-8","article-title":"Li-Wan Po A, Dornan JC. Is evening primrose oil of value in the treatment of premenstrual syndrome?","volume":"17","author":"Budieri, D.","year":"1996","unstructured":"Budieri D, Li-Wan Po A, Dornan JC. Is evening primrose oil of value in the treatment of premenstrual syndrome? Control Clin Trials 1996; 17: 60\u201368.","journal-title":"Control Clin Trials"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1046\/j.1440-1622.1999.01609.x","article-title":"Management of cyclical mastalgia in oriental women: pioneer experience of using gamolenic acid (Efamast) in Asia","volume":"69","author":"Cheung, K.L.","year":"1999","unstructured":"Cheung KL. Management of cyclical mastalgia in oriental women: pioneer experience of using gamolenic acid (Efamast) in Asia. Aust N Z J Surg 1999; 69: 492\u2013494.","journal-title":"Aust N Z J Surg"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0022-3999(92)90090-O","article-title":"A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive","volume":"36","author":"Graham, C.A.; Sherwin, B.B.","year":"1992","unstructured":"Graham CA, Sherwin BB. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive. J Psychosom Res 1992; 36: 257\u2013266.","journal-title":"J Psychosom Res"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1089\/15246090152543148","article-title":"Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder","volume":"10","author":"Freeman, E.W.; Kroll, R.; Rapkin, A.; Pearlstein, T.; Brown, C.; Parsey, K.","year":"2001","unstructured":"Freeman EW, Kroll R, Rapkin A, Pearlstein T, Brown C, Parsey K, et al.; PMS\/PMDD Research Group. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder. J Womens Health Gend Based Med 2001; 10: 561\u2013569.","journal-title":"J Womens Health Gend Based Med"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.contraception.2005.08.021","article-title":"Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation","volume":"72","author":"Pearlstein, T.B.; Bachmann, G.A.; Zacur, H.A.; Yonkers, K.A.","year":"2005","unstructured":"Pearlstein TB, Bachmann GA, Zacur HA, Yonkers KA. Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation. Contraception 2005; 72: 414\u2013421.","journal-title":"Contraception"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/01.AOG.0000175834.77215.2e","article-title":"Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder","volume":"106","author":"Yonkers, K.A.; Brown, C.; Pearlstein, T.B.; Foegh, M.; SampsonLanders, C.; Rapkin, A.","year":"2005","unstructured":"Yonkers KA, Brown C, Pearlstein TB, Foegh M, SampsonLanders C, Rapkin A. Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstet Gynecol 2005; 106: 492\u2013501.","journal-title":"Obstet Gynecol"},{"key":"ref_34","first-page":"261","article-title":"Hormone withdrawal symptoms in oral contraceptive users","volume":"95","author":"Sulak, P.J.; Scow, R.D.; Preece, C.; Riggs, M.W.; Kuehl, T.J.","year":"2000","unstructured":"Sulak PJ, Scow RD, Preece C, Riggs MW, Kuehl TJ. Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol 2000; 95: 261\u2013266.","journal-title":"Obstet Gynecol"},{"key":"ref_35","first-page":"1311","article-title":"Oral contraceptives and premenstrual symptoms: comparison of a 21\/7 and extended regimen","author":"Coffee, A.L.; Kuehl, T.J.; Willis, S.; Sulak, P.J.","year":"2006","unstructured":"Coffee AL, Kuehl TJ, Willis S, Sulak PJ. Oral contraceptives and premenstrual symptoms: comparison of a 21\/7 and extended regimen. Am J Obstet Gynecol 2006; 195: 1311\u20131319.","journal-title":"Am J Obstet Gynecol"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1136\/bmj.292.6536.1629","article-title":"Treatment of the premenstrual syndrome by subcutaneous oestradiol implants and cyclical oral norethisterone: placebo controlled study","volume":"292","author":"Magos, A.L.; Brincat, M.; Studd, J.","year":"1986","unstructured":"Magos AL, Brincat M, Studd J. Treatment of the premenstrual syndrome by subcutaneous oestradiol implants and cyclical oral norethisterone: placebo controlled study. BMJ 1986; 292: 1629\u20131633.","journal-title":"BMJ"},{"issue":"8665","key":"ref_37","first-page":"730","article-title":"Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone","volume":"2","author":"Watson, N.R.; Studd, J.W.W.; Savvas, M.; Garnett, T.; Baber, R.J.","year":"1989","unstructured":"Watson NR, Studd JWW, Savvas M, Garnett T, Baber RJ. Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone. Lancet 1989, 2(8665): 730\u2013732.","journal-title":"Lancet"},{"key":"ref_38","first-page":"475","article-title":"A randomised comparison over 8 months of 100 mg and","volume":"102","author":"Smith, R.N.J.; Studd, J.W.W.; Zamblera, D.; Holland, E.F.","year":"1995","unstructured":"Smith RNJ, Studd JWW, Zamblera D, Holland EF. A randomised comparison over 8 months of 100 mg and 200 mg twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndrome. Br J Obstet Gynaecol 1995; 102: 475\u2013484.","journal-title":"Br J Obstet Gynaecol; mg twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndrome"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/9781435628168-15","article-title":"The management of PMDD through ovarian cycle suppression","volume-title":"Premenstrual Syndromes: PMS and PMDD","author":"Panay, N.; Studd, J.","year":"2007","unstructured":"Panay N, Studd J. The management of PMDD through ovarian cycle suppression. In: S O\u2019Brien S, Rapkin AJ, Schmidt PJ (eds), Premenstrual Syndromes: PMS and PMDD. London, UK: Informa Healthcare, 2007; 121\u2013130."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/humupd\/3.2.159","article-title":"Progestogen intolerance and compliance with hormone replacement therapy in menopausal women","volume":"3","author":"Panay, N.; Studd, J.","year":"1997","unstructured":"Panay N, Studd J. Progestogen intolerance and compliance with hormone replacement therapy in menopausal women. Hum Reprod Update 1997; 3: 159\u2013171.","journal-title":"Hum Reprod Update"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1471-0528.1987.tb02248.x","article-title":"A clinical trial using danazol for the treatment of premenstrual tension","volume":"94","author":"Watts, J.F.; Butt, W.R.; Logan Edwards, R.","year":"1987","unstructured":"Watts JF, Butt WR, Logan Edwards R. A clinical trial using danazol for the treatment of premenstrual tension. Br J Obstet Gynaecol 1987; 94: 30\u201334.","journal-title":"Br J Obstet Gynaecol"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0306-4530(94)00053-D","article-title":"A randomised, placebocontrolled, crossover trial of danazol for the treatment of premenstrual syndrome","volume":"20","author":"Hahn, P.M.; Van Vugt, D.A.; Reid, R.L.","year":"1995","unstructured":"Hahn PM, Van Vugt DA, Reid RL. A randomised, placebocontrolled, crossover trial of danazol for the treatment of premenstrual syndrome. Psychoneuroendocrinology 1995, 20: 193\u2013209.","journal-title":"Psychoneuroendocrinology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1471-0528.2004.00135.x","article-title":"The effectiveness of GnRHa with and without \u2018add-back\u2019 therapy in treating premenstrual syndrome: a meta analysis","volume":"111","author":"Wyatt, K.M.; Dimmock, P.W.; Ismail, K.M.; Jones, P.W.; O\u2019Brien, P.M.","year":"2004","unstructured":"Wyatt KM, Dimmock PW, Ismail KM, Jones PW, O\u2019Brien PM. The effectiveness of GnRHa with and without \u2018add-back\u2019 therapy in treating premenstrual syndrome: a meta analysis. Br J Obstet Gynaecol 2004; 111: 585\u2013593.","journal-title":"Br J Obstet Gynaecol"},{"key":"ref_44","first-page":"104","article-title":"The prevention of bone loss in young women treated with GnRH analogues with add-back estrogen therapy","volume":"81","author":"Leather, A.T.; Studd, J.W.W.; Watson, N.R.; Holland, E.F.","year":"1993","unstructured":"Leather AT, Studd JWW, Watson NR, Holland EF. The prevention of bone loss in young women treated with GnRH analogues with add-back estrogen therapy. Obstet Gynecol 1993; 81: 104\u2013107.","journal-title":"Obstet Gynecol"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0015-0282(00)01707-6","article-title":"Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome","volume":"75","author":"C, Di Carlo; S, Palomba; GA, Tommaselli; M, Guida; A, Di Spiezio Sardo; C, Nappi","year":"2001","unstructured":"Di Carlo C, Palomba S, Tommaselli GA, Guida M, Di Spiezio Sardo A, Nappi C. Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome. Fertil Steril 2001; 75: 380\u2013384.","journal-title":"Fertil Steril"},{"key":"ref_46","first-page":"001297","article-title":"Gonadotrophinreleasing analogues for endometriosis: bone mineral density","author":"Sagsveen, M.; Farmer, J.; Prentice, A.; Breeze, A.","year":"2003","unstructured":"Sagsveen M, Farmer J, Prentice A, Breeze A. Gonadotrophinreleasing analogues for endometriosis: bone mineral density. Cochrane Database Syst Rev 2003; (4): CD001297.","journal-title":"Cochrane Database Syst Rev"},{"key":"ref_47","first-page":"1","article-title":"Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review","volume":"323","author":"Wyatt, K.; Dimmock, P.; Jones, P.; Obhrai, M.; O\u2019Brien, S.","year":"2001","unstructured":"Wyatt K, Dimmock P, Jones P, Obhrai M, O\u2019Brien S. Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review. BMJ 2001; 323: 1\u20138.","journal-title":"BMJ"},{"key":"ref_48","first-page":"589","article-title":"Investigation of the efficacy of progesterone pessaries in the relief of symptoms of premenstrual syndrome","volume":"45","author":"Magill, P.J.; Group, Progesterone Study","year":"1995","unstructured":"Magill PJ, Progesterone Study Group. Investigation of the efficacy of progesterone pessaries in the relief of symptoms of premenstrual syndrome. Br J Gen Pract 1995: 45: 589\u2013593.","journal-title":"Br J Gen Pract"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1093\/humrep\/deh354","article-title":"Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome","volume":"19","author":"Cronje, W.H.; Vashisht, A.; Studd, J.W.","year":"2005","unstructured":"Cronje WH, Vashisht A, Studd JW. Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome. Hum Reprod 2005; 19: 2152\u20132155.","journal-title":"Hum Reprod"},{"key":"ref_50","first-page":"1529","article-title":"Fluoxetine in the treatment of premenstrual dysphoria","volume":"23","author":"Steiner, M.; Steinberg, S.; Stewart, D.; Carter, D.; Berger, C.; Reid, R.; Grover, D.; Streiner, D.","year":"1995","unstructured":"Steiner M, Steinberg S, Stewart D, Carter D, Berger C, Reid R, Grover D, Streiner D. Fluoxetine in the treatment of premenstrual dysphoria. NEJM 1995;23:1529-1534.","journal-title":"NEJM"},{"key":"ref_51","first-page":"462","article-title":"The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder","volume":"108","author":"Steiner, M.; Romano, S.J.; Babcock, S.; Dillon, J.; Shuler, C.; Berger, C.","year":"2001","unstructured":"Steiner M, Romano SJ, Babcock S, Dillon J, Shuler C, Berger C, et al. The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder. Br J Obstet Gynecol 2001; 108: 462\u2013468.","journal-title":"Br J Obstet Gynecol"},{"issue":"9236","key":"ref_52","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0140-6736(00)02754-9","article-title":"Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review","volume":"356","author":"Dimmock, P.W.; Wyatt, K.M.; Jones, P.W.; O\u2019Brien, P.M.","year":"2000","unstructured":"Dimmock PW, Wyatt KM, Jones PW, O\u2019Brien PM. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet 2000; 356(9236): 1131\u20131136.","journal-title":"Lancet"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00004714-199902000-00002","article-title":"Full or half-cycle treatment of severe premenstrual syndrome with a serotonergic antidepressant","volume":"19","author":"Freeman, E.; Rickels, K.; Arredondo, F.; Kao, L.C.; Pollack, S.; Sondheimer, S.","year":"1999","unstructured":"Freeman E, Rickels K, Arredondo F, Kao LC, Pollack S, Sondheimer S. Full or half-cycle treatment of severe premenstrual syndrome with a serotonergic antidepressant. J Clin Psychopharmacol 1999; 19: 3\u20138.","journal-title":"J Clin Psychopharmacol"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jad.2004.10.006","article-title":"Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase","volume":"85","author":"Yonkers, K.; Pearlstein, T.; Fayyad, R.; Gillespie, J.","year":"2005","unstructured":"Yonkers K, Pearlstein T, Fayyad R, Gillespie J. Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase. J Affect Disord 2005; 85: 317\u2013321.","journal-title":"J Affect Disord"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/15246090260137635","article-title":"Citalopram in PMS patients with prior SSRI treatment failure: a preliminary study","volume":"11","author":"Freeman, E.W.; Jabara, S.; Sondheimer, S.J.; Auletto, R.","year":"2002","unstructured":"Freeman EW, Jabara S, Sondheimer SJ, Auletto R. Citalopram in PMS patients with prior SSRI treatment failure: a preliminary study. J Womens Health Gend Based Med 2002; 11: 459\u2013464.","journal-title":"J Womens Health Gend Based Med"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"769","DOI":"10.4088\/JCP.v66n0616","article-title":"A preliminary study of luteal phase versus symptom-onset dosing with escitalopram for PMDD","volume":"66","author":"Freeman, E.W.; Sondheimer, S.J.; Sammel, M.D.; Ferdousi, T.; Lin, H.","year":"2005","unstructured":"Freeman EW, Sondheimer SJ, Sammel MD, Ferdousi T, Lin H. A preliminary study of luteal phase versus symptom-onset dosing with escitalopram for PMDD. J Clin Psychiatry 2005; 66: 769\u2013773.","journal-title":"J Clin Psychiatry"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/01674820209074672","article-title":"A randomized comparison of psychological (cognitive behaviour therapy), medical (fluoxetine) and combined treatment for women with premenstrual dysphoric disorder","volume":"23","author":"Hunter, M.S.; Ussher, J.M.; Browne, S.J.; Cariss, M.; Jelley, R.; Katz, M.","year":"2002","unstructured":"Hunter MS, Ussher JM, Browne SJ, Cariss M, Jelley R, Katz M. A randomized comparison of psychological (cognitive behaviour therapy), medical (fluoxetine) and combined treatment for women with premenstrual dysphoric disorder. J Psychosom Obstet Gynaecol 2002; 23: 193\u2013199.","journal-title":"J Psychosom Obstet Gynaecol"},{"issue":"9619","key":"ref_58","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0140-6736(08)60527-9","article-title":"Premenstrual syndrome","volume":"371","author":"Yonkers, K.A.; O\u2019Brien, P.M.; Eriksson, E.","year":"2008","unstructured":"Yonkers KA, O\u2019Brien PM, Eriksson E. Premenstrual syndrome. Lancet 2008; 371(9619): 1200\u20131210.","journal-title":"Lancet"},{"key":"ref_59","first-page":"26","article-title":"Understanding the pain: managing severe PMS","volume":"11","author":"Panay, N.","year":"2008","unstructured":"Panay N. Understanding the pain: managing severe PMS. Pract Midwife 2008; 11: 26\u201329.","journal-title":"Pract Midwife"},{"key":"ref_60","first-page":"181","article-title":"Management of severe premenstrual syndrome","volume-title":"The Year in Obstetrics & Gynaecology","author":"Further reading\/information 1 Ng C, Cloke B, Panay N","unstructured":"Further reading\/information 1 Ng C, Cloke B, Panay N. Management of severe premenstrual syndrome. In: Barter J, Hampton N (eds), The Year in Obstetrics & Gynaecology. Oxford, UK: Clinical Publishing Services, 2002; Part III, 181\u2013196."},{"key":"ref_61","article-title":"PJ (eds). Premenstrual Syndromes: PMS and PMDD","author":"O\u2019Brien, S.; Rapkin, A.J.; Schmidt","year":"2007","unstructured":"O\u2019Brien S, Rapkin AJ, Schmidt PJ (eds). Premenstrual Syndromes: PMS and PMDD. London, UK: Informa Healthcare, 2007."},{"key":"ref_62","article-title":"Premenstrual Syndrome (NAPS). Advice for sufferers and health professionals","author":"National Association for","unstructured":"National Association for Premenstrual Syndrome (NAPS). Advice for sufferers and health professionals. Website: www.pms.org.uk."},{"key":"ref_63","article-title":"Visit the Faculty Website","unstructured":"Visit the Faculty Website at www.fsrh.org"}],"container-title":["Journal of Family Planning and Reproductive Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1783\/147118909788708147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T04:53:34Z","timestamp":1756875214000},"score":1,"resource":{"primary":{"URL":"https:\/\/jfprhc.bmj.com\/lookup\/doi\/10.1783\/147118909788708147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":63,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,7,1]]},"published-print":{"date-parts":[[2009,7]]}},"alternative-id":["10.1783\/147118909788708147"],"URL":"https:\/\/doi.org\/10.1783\/147118909788708147","relation":{},"ISSN":["1471-1893","2045-2098"],"issn-type":[{"value":"1471-1893","type":"print"},{"value":"2045-2098","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}